Create website screenshot

Create

CREATE Medicines is a Cambridge, Massachusetts biopharmaceutical company developing in vivo CAR (chimeric antigen receptor) cell therapies using mRNA lipid-nanoparticle (mRNA-LNP) delivery. Its platform reprograms immune cells, including T cells, NK cells, and myeloid cells, directly inside the body rather than extracting and engineering them ex vivo, with clinical and preclinical programs spanning oncology, autoimmune disease, and fibrosis. Surfaced as a portfolio company of 8vc and added to the API Evangelist network as a stub. The enrichment pipeline found no developer or API surface; this is a clinical-stage therapeutics company, not a software or platform provider, so no API artifacts were produced (none is the correct, non-fabricated result).

Create is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Cell Therapy, mRNA, and Oncology.

11.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiopharmaceuticalCell TherapymRNAOncologyImmunologyBiotechnology

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.0/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/create: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 2

Pricing, plans, and the legal terms of use

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: create
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/create.png
name: Create
description: CREATE Medicines is a Cambridge, Massachusetts biopharmaceutical company developing in vivo CAR (chimeric antigen
  receptor) cell therapies using mRNA lipid-nanoparticle (mRNA-LNP) delivery. Its platform reprograms immune cells, including
  T cells, NK cells, and myeloid cells, directly inside the body rather than extracting and engineering them ex vivo, with
  clinical and preclinical programs spanning oncology, autoimmune disease, and fibrosis. Surfaced as a portfolio company of
  8vc and added to the API Evangelist network as a stub. The enrichment pipeline found no developer or API surface; this is
  a clinical-stage therapeutics company, not a software or platform provider, so no API artifacts were produced (none is the
  correct, non-fabricated result).
url: https://raw.githubusercontent.com/api-evangelist/create/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- 8vc
x-tier: stub
x-tier-reason: portfolio-lead
x-api-surface: none
x-industry: biopharmaceutical
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biopharmaceutical
- Cell Therapy
- mRNA
- Oncology
- Immunology
- Biotechnology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://createmedicines.com
- type: PrivacyPolicy
  url: https://createmedicines.com/privacy-policy
- type: TermsOfService
  url: https://createmedicines.com/terms-of-use
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence